All journal publications

Found 14 results. Export: Tagged | XML
Filters: author is Amorij  [Clear All Filters]
2015
Soema, P.C., van Riet, E., Kersten, G., Amorij, J.P. , Development of cross-protective influenza A vaccines based on cellular responses, Frontiers in Immunology, vol. 6, pp. 1-9. DOI
Soema, P.C., Kompier, R., Amorij, J.P., Kersten, G.F. , Current and next generation influenza vaccines: Formulation and production strategies, Eur J Pharm Biopharm, vol. 94, pp. 251–263. DOI
Kraan, H., Ploemen, I, van de Wijdeven, G., Que, I, Lowik, C., Kersten, G., Amorij, J.P. , Alternative delivery of a thermostable inactivated polio vaccine, Vaccine, vol. 33, no. 17, pp. 2030-7. DOI
Soema, P.C., Rosendahl Huber, S.K., Willems, G.J., Jiskoot, W., Kersten, G.F., Amorij, J.P. , Influenza T-cell epitope-loaded virosomes adjuvanted with CpG as a potential influenza vaccine, Pharm Res, vol. 32, no. 4, pp. 1505-15. DOI
2014
Kraan, H., van Herpen, P., Kersten, G., Amorij, J.P. , Development of thermostable lyophilized inactivated polio vaccine, Pharm Res, vol. 31, no. 10, pp. 2618-29. DOI
Tonnis, W.F., Amorij, J.P., Vreeman, M.A., Frijlink, H.W., Kersten, G.F., Hinrichs, W.L. , Improved storage stability and immunogenicity of hepatitis B vaccine after spray-freeze drying in presence of sugars, Eur J Pharm Sci, vol. 55, pp. 36-45. DOI
Soema, P.C., Willems, G.J., van Twillert, K., van de Wijdeven, G., Boog, C.J., Kersten, G.F.A., Amorij, J.P. , Solid Bioneedle-Delivered Influenza Vaccines Are Highly Thermostable and Induce Both Humoral and Cellular Immune Responses, Plos One, vol. 9, no. 3. DOI
Kraan, H., Vrieling, H., Czerkinsky, C., Jiskoot, W., Kersten, G., Amorij, J.P. , Buccal and sublingual vaccine delivery, Journal of controlled release : official journal of the Controlled Release Society, vol. 190, pp. 580-592. DOI
Ploemen, I.H.J., Hirschberg, H.J.H.B., Kraan, H., Zeltner, A., van Kuijk, S., Lankveld, D.P.K., Royals, M., Kersten, G.F.A., Amorij, J.P. , Minipigs as an Animal Model for Dermal Vaccine Delivery, Comparative Medicine, vol. 64, no. 1, pp. 50-54.
2012
Amorij, J.P., Kersten, G.F., Saluja, V., Tonnis, W.F., Hinrichs, W.L., Slutter, B., Bal, S.M., Bouwstra, J.A., Huckriede, A., Jiskoot, W. , Towards tailored vaccine delivery: Needs, challenges and perspectives, J Contr Rel, vol. 161, issue 2, pp. 363-376. DOI
Hirschberg, H., van Kuijk, S., Loch, J., Jiskoot, W., Bouwstra, J., Kersten, G., Amorij, J.P. , A combined approach of vesicle formulations and microneedle arrays for transcutaneous immunization against hepatitis B virus, Eur J Pharm Sci, vol. 46, issue 1-2, pp. 1-7. DOI
Tafaghodi, M., Saluja, V., Kersten, G.F., Kraan, H., Slutter, B., Amorij, J.P., Jiskoot, W. , Hepatitis B surface antigen nanoparticles coated with chitosan and trimethyl chitosan: Impact of formulation on physicochemical and immunological characteristics, Vaccine, vol. 30, no. 36, pp. 5341-8. DOI
2011
Avanti, C., Amorij, J.P., Setyaningsih, D., Hawe, A., Jiskoot, W., Visser, J., Kedrov, A., Driessen, A.J., Hinrichs, W.L., Frijlink, H.W. , A New Strategy to Stabilize Oxytocin in Aqueous Solutions: I. The Effects of Divalent Metal Ions and Citrate Buffer, AAPS J, vol. 13, issue 2, pp. 284-290. DOI